Get it on Google Play

BetterLife Pharma hires Nucro-Technics for final BETR-001 toxicology study

July 6, 2026 8:02 AM EDT Send to a Friend
BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) has engaged Nucro-Technics Inc. to conduct the final IND-enabling GLP toxicology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login